<p>Cyanotech Corp（CYAN）发布了其第二季度财报。以下是 Cyanotech Corp 向投资者提供的信息摘要。</p>
<h3>认识您的 ETF AI 分析师</h3>
<ul>
<li>了解 TipRanks 的_ETF_ AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong><em>ETF</em> AI 分析师</strong> 对您关注的 ETF 所揭示的见解。</li>
</ul>
<p>Cyanotech Corporation 总部位于夏威夷凯鲁瓦 - 科纳，专注于生产源自微藻的天然膳食补充剂，主要为健康和保健行业提供产品，如夏威夷螺旋藻和 BioAstin 夏威夷虾青素。</p>
<p>在截至 2025 年 9 月 30 日的最新财报中，Cyanotech Corporation 报告了财务表现的显著改善，净收入为 1,000 美元，而去年同期净亏损为 115 万美元。这一积极变化得益于净销售额的增加，从 584.5 万美元上升至 697.6 万美元，反映出对其微藻基产品的需求不断增长。</p>
<p>关键财务亮点包括毛利润从 147.9 万美元增加至 239.3 万美元，这归因于销售额的提高和成本管理的改善。运营费用略有下降，帮助公司从亏损转向盈利。公司还成功大幅减少了短期银行债务，表明财务状况更为稳健。然而，持续的债务契约合规问题仍然是挑战，公司正在通过豁免和战略财务管理来应对。</p>
<p>展望未来，Cyanotech Corporation 的管理层对其维持积极财务势头的能力保持谨慎乐观，专注于节约成本的举措，并使生产与市场需求保持一致。公司在稳定财务健康和扩大市场影响力方面的战略努力预计将继续，尽管承认经济条件和融资限制可能带来的潜在风险。</p>

赛安诺科技

CYAND

<p>赛安诺科技 (Cyanotech Corp, CYAN) 报告了积极的第二季度财报，净收入为 1,000 美元，较去年 115 万美元的亏损实现了显著扭转。销售额增长至 697.6 万美元，主要受其基于微藻产品的需求推动。毛利润上升至 239.3 万美元，而运营费用则有所减少。公司减少了短期银行债务，但在债务契约合规方面面临挑战。管理层对通过节省成本的举措和将生产与市场需求对接来维持财务势头持谨慎乐观态度，尽管存在潜在的经济风险</p>

<p>Cyanotech Corp ( (CYAN) ) has released its Q2 earnings. Here is a breakdown of the information Cyanotech Corp presented to its investors.</p>
<div class="lb-trans"><p>Cyanotech Corp（CYAN）发布了其第二季度财报。以下是 Cyanotech Corp 向投资者提供的信息摘要。</p>
</div><h3>Meet Your ETF AI Analyst</h3>
<div class="lb-trans"><h3>认识您的 ETF AI 分析师</h3>
</div><ul>
<li>Discover how TipRanks' <em>ETF</em> AI Analyst can help you make smarter investment decisions</li>
<li>Explore ETFs TipRanks' users love and see what insights the <strong><em>ETF</em> AI Analyst</strong> reveals about the ones you follow.</li>
</ul>
<div class="lb-trans"><ul>
<li>了解 TipRanks 的_ETF_ AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong><em>ETF</em> AI 分析师</strong> 对您关注的 ETF 所揭示的见解。</li>
</ul>
</div><p>Cyanotech Corporation, based in Kailua-Kona, Hawaii, is a company specializing in the production of natural dietary supplements derived from microalgae, primarily serving the health and wellness industry with products like Hawaiian Spirulina Pacifica and BioAstin Hawaiian Astaxanthin.</p>
<div class="lb-trans"><p>Cyanotech Corporation 总部位于夏威夷凯鲁瓦 - 科纳，专注于生产源自微藻的天然膳食补充剂，主要为健康和保健行业提供产品，如夏威夷螺旋藻和 BioAstin 夏威夷虾青素。</p>
</div><p>In its latest earnings report for the quarter ending September 30, 2025, Cyanotech Corporation reported a notable improvement in financial performance, achieving a net income of $1,000 compared to a net loss of $1.15 million in the same period last year. This positive shift was driven by increased net sales, which rose to $6.976 million from $5.845 million, reflecting a growing demand for its microalgae-based products.</p>
<div class="lb-trans"><p>在截至 2025 年 9 月 30 日的最新财报中，Cyanotech Corporation 报告了财务表现的显著改善，净收入为 1,000 美元，而去年同期净亏损为 115 万美元。这一积极变化得益于净销售额的增加，从 584.5 万美元上升至 697.6 万美元，反映出对其微藻基产品的需求不断增长。</p>
</div><p>Key financial highlights include a gross profit increase to $2.393 million from $1.479 million, attributable to higher sales and improved cost management. Operating expenses decreased slightly, aiding in the transition from a loss to a profit. The company also managed to reduce its short-term bank debt significantly, indicating a stronger financial position. However, challenges remain with ongoing debt covenant compliance issues, which the company is addressing through waivers and strategic financial management.</p>
<div class="lb-trans"><p>关键财务亮点包括毛利润从 147.9 万美元增加至 239.3 万美元，这归因于销售额的提高和成本管理的改善。运营费用略有下降，帮助公司从亏损转向盈利。公司还成功大幅减少了短期银行债务，表明财务状况更为稳健。然而，持续的债务契约合规问题仍然是挑战，公司正在通过豁免和战略财务管理来应对。</p>
</div><p>Looking forward, Cyanotech Corporation’s management remains cautiously optimistic about its ability to maintain positive financial momentum, focusing on cost-saving initiatives and aligning production with market demand. The company’s strategic efforts to stabilize its financial health and expand its market presence are expected to continue, albeit with an acknowledgment of the potential risks posed by economic conditions and financing constraints.</p>
<div class="lb-trans"><p>展望未来，Cyanotech Corporation 的管理层对其维持积极财务势头的能力保持谨慎乐观，专注于节约成本的举措，并使生产与市场需求保持一致。公司在稳定财务健康和扩大市场影响力方面的战略努力预计将继续，尽管承认经济条件和融资限制可能带来的潜在风险。</p>
</div>

赛安诺科技公司报告称在销售增长的推动下实现了正收益